Congress Wants More Answers From J&J On "Phantom Recall"
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson's response to a congressional inquiry regarding the alleged "phantom recall" of a Motrin product left a House committee chairman considering whether to subpoena additional information
You may also be interested in...
Consumer Lawsuits Allege J&J Concealed OTC Defects
Johnson & Johnson faces lawsuits filed by consumers in federal court, alleging fraud and other problems leading up to and following the firm's extensive recall of pediatric OTC drug products
Consumer Lawsuits Allege J&J Concealed OTC Defects
Johnson & Johnson faces lawsuits filed by consumers in federal court, alleging fraud and other problems leading up to and following the firm's extensive recall of pediatric OTC drug products
Consumer Lawsuits Allege J&J Concealed OTC Defects
Johnson & Johnson faces lawsuits filed by consumers in federal court, alleging fraud and other problems leading up to and following the firm's extensive recall of pediatric OTC drug products